Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONSENT: Metformin XR vs IR in Type 2 Diabetes
NCT02252965Phase 4Completed
- Sponsor
- Merck KGaA
- Start
- Dec 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM), sponsored by Merck KGaA. Started Dec 2014; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02252965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02252965.